日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cavity-altered superconductivity

腔体改变的超导性

Keren, Itai; Webb, Tatiana A; Zhang, Shuai; Xu, Jikai; Sun, Dihao; Kim, Brian S Y; Shin, Dongbin; Zhang, Songtian S; Zhang, Junhe; Pereira, Giancarlo; Yao, Juntao; Okugawa, Takuya; Michael, Marios H; Viñas Boström, Emil; Edgar, James H; Wolf, Stuart; Julian, Matthew; Prasankumar, Rohit P; Miyagawa, Kazuya; Kanoda, Kazushi; Gu, Genda; Cothrine, Matthew; Mandrus, David; Buzzi, Michele; Cavalleri, Andrea; Dean, Cory R; Kennes, Dante M; Millis, Andrew J; Li, Qiang; Sentef, Michael A; Rubio, Angel; Pasupathy, Abhay N; Basov, D N

Therapeutic advances in pruritus as a model of personalized medicine

瘙痒症治疗进展:个性化医疗的典范

Auyeung, Kelsey; Kubofcik, Ramsey; Kim, Brian S

Updates on Kinase Inhibitors in Allergy

过敏症中激酶抑制剂的最新进展

Dispenza, Melanie C; Kim, Brian S

Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria

度普利尤单抗可减轻临床上不同的皮肤疾病引起的瘙痒:来自特应性皮炎、结节性痒疹和慢性自发性荨麻疹临床试验的数据

Yosipovitch, Gil; Kim, Brian S; Koo, John Y; Chen, Zhen; Wiggins, Simmi; Zahn, Joseph; Sugerman, Philip; Haddad, El-Bdaoui; Cyr, Sonya L

Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria

更正:度普利尤单抗可减轻临床上不同的皮肤疾病引起的瘙痒:来自特应性皮炎、结节性痒疹和慢性自发性荨麻疹临床试验的数据

Yosipovitch, Gil; Kim, Brian S; Koo, John Y; Chen, Zhen; Wiggins, Simmi; Zahn, Joseph; Sugerman, Philip; Haddad, El-Bdaoui; Cyr, Sonya L

Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies

Dupilumab 改善结节性痒疹成人患者的日常症状负担:LIBERTY PN-PRIME 和 PRIME2 研究的事后分析

Kwatra, Shawn G; Ständer, Sonja; Kim, Brian S; Msihid, Jerome; Bansal, Ashish; Makhija, Melanie; Wiggins, Simmi; Zahn, Joseph; Thomas, Ryan B; Bahloul, Donia

Efficacy of Lebrikizumab on Pruritus: A Narrative Review

Lebrikizumab治疗瘙痒症的疗效:叙述性综述

Yosipovitch, Gil; Kim, Brian S; Ständer, Sonja; Elmariah, Sarina B; Prajapati, Vimal H; Kabashima, Kenji; Gallo, Gaia; Rueda, Maria Jose; Pierce, Evangeline; Ding, Yuxin; Kwatra, Shawn G

Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials

Dupilumab治疗伴或不伴特应性合并症的成人结节性痒疹的疗效和安全性:两项随机III期临床试验的亚组分析

Kim, Brian S; Gonçalo, Margarida; Ugajin, Tsukasa; Gao, Xing-Hua; Praestgaard, Amy H; Makhija, Melanie; Zahn, Joseph; Bansal, Ashish; Wiggins, Simmi

A multidisciplinary Delphi consensus on the modern definition of pruritus: Sensation and disease

关于瘙痒症现代定义的多学科德尔菲共识:感觉与疾病

Ständer, Sonja; Schmelz, Martin; Lerner, Ethan; Murota, Hiroyuki; Nattkemper, Leigh; Reich, Adam; Stahl, Lea-Sophie; Yosipovitch, Gil; Weisshaar, Elke; Wiegmann, Henning; Apfelbacher, Christian; Kim, Brian S

RAG suppresses group 2 innate lymphoid cells

RAG抑制2型固有淋巴细胞

Ver Heul, Aaron M; Mack, Madison; Zamidar, Lydia; Tamari, Masato; Yang, Ting-Lin; Trier, Anna M; Kim, Do-Hyun; Janzen-Meza, Hannah; Van Dyken, Steven J; Hsieh, Chyi-Song; Karo, Jenny M; Sun, Joseph C; Kim, Brian S